RESPIT, regionally-specific immunotherapy, is the practical allergy immunotherapy alternative that you can prescribe for atopic dermatitis in dogs and cats without allergy testing.  I recently conducted a survey of all 160 veterinarians who had prescribed RESPIT Injectable prior to September 30, 2012.  (That number is now over 500, but we wanted to hear from those that had had a chance to follow up patients for at least 9 months.)  I asked veterinarians to assess the efficacy and safety of RESPIT in each of their patients meeting certain inclusion criteria, and also asked some questions concerning their overall impression of RESPIT.  I am going to share the patient-specific information elsewhere, but here are the overall impression results from the 15 veterinarians who completed the survey.

• 100% of veterinarians responded that RESPIT is equal to or more effective than allergy-test based immunotherapy.

• 80% of veterinarians responded that they are very likely or extremely likely to recommend RESPIT to a colleague.

• 100% considered adverse reactions with RESPIT to be equal to or less frequent than with immunotherapy customized based on allergy test results.